In a study that evaluated the effect of nutraceuticals, including resveratrol, on the inhibition of cervical cancer through the reactivation of PAX1, it was reported that resveratrol was capable of reactivating PAX1 expression in Caski cells [72]. The gene discussed is PAX1; the disease is cervical cancer.